Company news
Ardelyx, Inc. news in 2024
Ardelyx, Inc.'s news releases, calls and decks from 2024, newest first.
Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
November 19, 2024
Ardelyx Responds to District Court Decision Granting Motion to Dismiss
November 7, 2024
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference
November 4, 2024
Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update
October 30, 2024
Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting
October 27, 2024
Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week
October 23, 2024
Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community
October 21, 2024
Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community
October 20, 2024
Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024
October 16, 2024
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week
October 14, 2024
Ardelyx Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology
October 8, 2024
Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference
September 4, 2024
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
August 7, 2024
Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update
July 31, 2024
Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion
July 30, 2024
Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024
July 17, 2024
Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines
July 16, 2024
To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA
July 1, 2024
Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines
June 27, 2024
Ardelyx, Inc. Reports Employment Inducement Grants
May 29, 2024
Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
May 21, 2024
Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults
May 20, 2024
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
May 15, 2024
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
May 6, 2024
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
May 1, 2024
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
April 30, 2024
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
April 17, 2024
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
March 24, 2024
Ardelyx to Participate at the Cowen 44th Annual Health Care Conference
February 26, 2024
Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 21, 2024
Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
January 31, 2024
Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities
January 7, 2024
Ardelyx to Provide Company Update on IBSRELA® and Host a KOL Discussion on the IBS-C Landscape on Monday, January 8
January 2, 2024